Cargando…
Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646021/ https://www.ncbi.nlm.nih.gov/pubmed/19074997 http://dx.doi.org/10.2337/dc08-1265 |
_version_ | 1782164807767556096 |
---|---|
author | Harita, Nobuko Hayashi, Tomoshige Sato, Kyoko Kogawa Nakamura, Yoshiko Yoneda, Takeshi Endo, Ginji Kambe, Hiroshi |
author_facet | Harita, Nobuko Hayashi, Tomoshige Sato, Kyoko Kogawa Nakamura, Yoshiko Yoneda, Takeshi Endo, Ginji Kambe, Hiroshi |
author_sort | Harita, Nobuko |
collection | PubMed |
description | OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated with type 2 diabetes. RESEARCH DESIGN AND METHODS—The study participants were nondiabetic Japanese men (n = 8,570) aged 40–55 years at entry. Type 2 diabetes was diagnosed if fasting plasma glucose was ≥126 mg/dl or if participants were taking oral hypoglycemic medication or insulin. RESULTS—During the 4-year follow-up period, 877 men developed type 2 diabetes. Lower serum creatinine was associated with an increased risk of type 2 diabetes. The multiple-adjusted odds ratio for those who had serum creatinine levels between 0.40 and 0.60 mg/dl was 1.91 (95% CI 1.44–2.54) compared with those who had levels between 0.71 and 0.80 mg/dl. CONCLUSIONS—Lower serum creatinine increased the risk of type 2 diabetes. |
format | Text |
id | pubmed-2646021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-26460212010-03-01 Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study Harita, Nobuko Hayashi, Tomoshige Sato, Kyoko Kogawa Nakamura, Yoshiko Yoneda, Takeshi Endo, Ginji Kambe, Hiroshi Diabetes Care Epidemiology/Health Services Research OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated with type 2 diabetes. RESEARCH DESIGN AND METHODS—The study participants were nondiabetic Japanese men (n = 8,570) aged 40–55 years at entry. Type 2 diabetes was diagnosed if fasting plasma glucose was ≥126 mg/dl or if participants were taking oral hypoglycemic medication or insulin. RESULTS—During the 4-year follow-up period, 877 men developed type 2 diabetes. Lower serum creatinine was associated with an increased risk of type 2 diabetes. The multiple-adjusted odds ratio for those who had serum creatinine levels between 0.40 and 0.60 mg/dl was 1.91 (95% CI 1.44–2.54) compared with those who had levels between 0.71 and 0.80 mg/dl. CONCLUSIONS—Lower serum creatinine increased the risk of type 2 diabetes. American Diabetes Association 2009-03 /pmc/articles/PMC2646021/ /pubmed/19074997 http://dx.doi.org/10.2337/dc08-1265 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Epidemiology/Health Services Research Harita, Nobuko Hayashi, Tomoshige Sato, Kyoko Kogawa Nakamura, Yoshiko Yoneda, Takeshi Endo, Ginji Kambe, Hiroshi Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title | Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title_full | Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title_fullStr | Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title_full_unstemmed | Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title_short | Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study |
title_sort | lower serum creatinine is a new risk factor of type 2 diabetes: the kansai healthcare study |
topic | Epidemiology/Health Services Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646021/ https://www.ncbi.nlm.nih.gov/pubmed/19074997 http://dx.doi.org/10.2337/dc08-1265 |
work_keys_str_mv | AT haritanobuko lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT hayashitomoshige lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT satokyokokogawa lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT nakamurayoshiko lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT yonedatakeshi lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT endoginji lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy AT kambehiroshi lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy |